Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 6/20 | 0.47 |
| ▸ | HTR2A | P28223 | 4/20 | 0.47 |
| ▸ | HTR2B | P41595 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 2/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29812920 | 1.00 | HTR2C (0.47) | HTR2CHTR2AHTR2BKDM4EMEN1 | |
| SCHEMBL11741195 | 0.85 | HTR2C (0.50) | HTR2CHTR2AHTR2BKDM4EMEN1 | |
| SCHEMBL22194113 | 0.81 | KDM4E (0.34) | KDM4EMEN1KMT2ATSHR | |
| SCHEMBL18587142 | 0.80 | HTR2C (0.37) | HTR2CHTR2AHTR2BKDM4EMEN1 | |
| SCHEMBL4381845 | 0.78 | MEN1 (0.36) | HTR2CHTR2AHTR2BKDM4EMEN1 | |
| SCHEMBL1265478 | 0.78 | GABRA1 (0.35) | HTR2CHTR2AHTR2BKDM4EMEN1 | |
| SCHEMBL29813196 | 0.78 | GABRA1 (0.35) | HTR2CHTR2AHTR2BKDM4EMEN1 | |
| SCHEMBL1733021 | 0.77 | CYP1A2 (0.38) | HTR2CHTR2AHTR2BKDM4EMEN1 | |
| SCHEMBL1739919 | 0.77 | HTR2A (0.47) | HTR2CHTR2AHTR2BKDM4EKDM1A | |
| SCHEMBL1741315 | 0.77 | KDM1A (0.53) | HTR2CHTR2AHTR2BKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119948116-A | Coating composition with polyolefin network structure | SWIMC有限公司 | 2025-05-06 | — | — | CN | claimed |
| EP-3013886-B1 | THERMAL INSULATION | MATERIA INC (US) | 2025-03-26 | — | — | EP | claimed |
| US-10711090-B2 | Thermal insulation | MATERIA, INC. (US) | 2020-07-14 | — | — | US | claimed |
| US-6811846-B1 | THREE- OR FIVE-LAYERED LAMINATED PLASTIC MOLDED BODY HAVING POLYETHYLENE TEREPHTHALATE LAYERS LAMINATED ALTERNATELY WITH POLYOLEFIN RESIN LAYERS HAVING CYCLIC OLEFIN COMPONENT; TRANSPARENT, OIL RESISTANT, VAPOR BARRIER PROPERTIES | YOSHINO KOGYOSHO CO., LTD. (JP) | 2004-11-02 | — | — | US | claimed |
| EP-0446051-B1 | Process for the production of cycloolefin-based random copolymer | MITSUI PETROCHEMICAL IND (JP) | 1995-11-15 | — | — | EP | claimed |
| EP-0325260-B1 | Random copolymer containing derivative of bicyclo (2.2.1) hept-2-ene compound | NIPPON OIL CO LTD (JP) | 1994-11-02 | — | — | EP | claimed |
| US-5142007-A | Copolymerizing with ethylene and at least one unsaturated monomer in presence of catalysts and mixed solvent | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1992-08-25 | — | — | US | claimed |
| EP-0446051-A1 | Process for the production of cycloolefin-based random copolymer | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-09-11 | — | — | EP | claimed |
| WO-2026090602-A1 | PIGMENTED RESIN AND CATALYST COMPOSITIONS | MATERIA, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260098182-A1 | COATING COMPOSITIONS WITH POLYOLEFIN NETWORK STRUCTURE | SWIMC LLC (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4112671-B1 | CYCLOOLEFIN RING-OPENED COPOLYMER, COMPOSITION FOR ELECTRICALLY INSULATING MATERIAL, AND ELECTRICALLY INSULATING MATERIAL | ZEON CORP (JP) | 2026-04-08 | — | — | EP | disclosed |
| EP-4683900-A2 | ROMP AND THERMAL INSULATION COMPOSITIONS AND MATERIALS AND USE THEREOF | Materia, Inc. (US) | 2026-01-28 | — | — | EP | disclosed |
| WO-2025245037-A1 | CYCLIC OLEFIN COMPOSITIONS, ROMP COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF | MATERIA, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| US-12428521-B2 | Cycloolefin ring-opened copolymer, composition for electrically insulating material, and electrically insulating material | ZEON CORPORATION (JP) | 2025-09-30 | — | — | US | disclosed |
| US-5059487-A | Cyclic olefin-olefin random copolymer | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-10-22 | — | — | US | disclosed |
| EP-0447072-A2 | Cycloolefin random copolymer and process for preparing same | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-09-18 | — | — | EP | disclosed |
| EP-0446051-A1 | Process for the production of cycloolefin-based random copolymer | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-09-11 | — | — | EP | disclosed |
| EP-0414258-A2 | Information recording medium and adhesive composition therefor | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-02-27 | — | — | EP | disclosed |
| US-4990559-A | Thermoplastic resin composition | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-02-05 | — | — | US | disclosed |
| US-4033982-A | REACTING NORBORNENES WITH SULFUR | GENERAL ELECTRIC COMPANY (US) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098182-A1 | COATING COMPOSITIONS WITH POLYOLEFIN NETWORK STRUCTURE | POT1, CD40, CAD | HTR2C 865/4885HTR2A 1325/4885HTR2B 2757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.